Cognitive Disorders

Citations 91-100 of 267 total displayed.

Past content (since Jan 1998):

Original Contributions
Novel Panel of Cerebrospinal Fluid Biomarkers for the Prediction of Progression to Alzheimer Dementia in Patients With Mild Cognitive Impairment

Anja H. Simonsen; James McGuire; Oskar Hansson; Henrik Zetterberg; Vladimir N. Podust; Huw A. Davies; Gunhild Waldemar; Lennart Minthon; Kaj Blennow
Arch Neurol 2007; 64: 366-370. [Abstract] [Full text] [PDF]  

Original Contributions
Incidence of Dementia in Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study

Oscar L. Lopez; Lewis H. Kuller; James T. Becker; Corinne Dulberg; Robert A. Sweet; H. Michael Gach; Steven T. DeKosky
Arch Neurol 2007; 64: 416-420. [Abstract] [Full text] [PDF]  

Original Contributions
Cerebrospinal Fluid tau/-Amyloid₄₂ Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults

Anne M. Fagan; Catherine M. Roe; Chengjie Xiong; Mark A. Mintun; John C. Morris; David M. Holtzman
Arch Neurol 64.3.noc60123. [Abstract] [Full text] []  

Original Contributions
Qualitative Estimates of Medial Temporal Atrophy as a Predictor of Progression From Mild Cognitive Impairment to Dementia

Charles DeCarli; Giovanni B. Frisoni; Christopher M. Clark; Danielle Harvey; Michael Grundman; Ronald C. Petersen; Leon J. Thal; Shelia Jin; Clifford R. Jack Jr; Philip Scheltens; for the Alzheimer's Disease Cooperative Study Group
Arch Neurol 2007; 64: 108-115. [Abstract] [Full text] [PDF]  

Original Contributions
Motor Dysfunction in Mild Cognitive Impairment and the Risk of Incident Alzheimer Disease

Neelum T. Aggarwal; Robert S. Wilson; Todd L. Beck; Julia L. Bienias; David A. Bennett
Arch Neurol 2006; 63: 1763-1769. [Abstract] [Full text] [PDF]  

Original Contributions
Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging

Marwan N. Sabbagh; Flora Shah; Richard T. Reid; Lucia Sue; Donald J. Connor; Lars Kristofer N. Peterson; Thomas G. Beach
Arch Neurol 2006; 63: 1771-1776. [Abstract] [Full text] [PDF]  

Neurological Reviews
Cognitive Dysfunction in Schizophrenia: Convergence of -Aminobutyric Acid and Glutamate Alterations

David A. Lewis; Bita Moghaddam
Arch Neurol 2006; 63: 1372-1376. [Abstract] [Full text] [PDF]  

Original Contributions
-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial

Yvonne Freund-Levi; Maria Eriksdotter-Jönhagen; Tommy Cederholm; Hans Basun; Gerd Faxén-Irving; Anita Garlind; Inger Vedin; Bengt Vessby; Lars-Olof Wahlund; Jan Palmblad
Arch Neurol 2006; 63: 1402-1408. [Abstract] [Full text] [PDF]  

Original Contributions
Cognitive Impairment and Celiac Disease

William T. Hu; Joseph A. Murray; Melanie C. Greenaway; Joseph E. Parisi; Keith A. Josephs
Arch Neurol 2006; 63: 1440-1446. [Abstract] [Full text] [PDF]  

Original Contributions
The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer Disease

Karina Stavitsky; Adam M. Brickman; Nikolaos Scarmeas; Rebecca L. Torgan; Ming-Xin Tang; Marilyn Albert; Jason Brandt; Deborah Blacker; Yaakov Stern
Arch Neurol 2006; 63: 1450-1456. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27